Area of research
Reproductive Medicine · Oncology
Research interest
Research interests include Medicine, Ovarian cancer, Oncology, Bevacizumab, Internal medicine, and Olaparib.
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer—A Study of the GANNET53 Consortium
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer